CHIME BioTherapeutics' Incubator/Accelerator Round

CHIME BioTherapeutics raised a round of funding on May 01, 2017. Investors include JLabs.

CHIME BioTherapeutics, Inc. is an immuno-oncology company focused on the development of cancer immunotherapies based on the concept of recalling and harnessing pre-existing memory immunity from childh…

Articles about CHIME BioTherapeutics' Incubator/Accelerator Round: